Pinpointing how tumors reprogram platelets and trigger blood clots
Study showed that regimen was well-tolerated in cohort with aggressive carcinoma
Study opens new line of research for treatment-resistant tumors
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy